Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial (BEGIN: ADD TO GLP‐1 Study)

AIM: To evaluate the efficacy and safety of adding insulin degludec (IDeg) to treatment in patients with type 2 diabetes receiving liraglutide and metformin and qualifying for treatment intensification because of inadequate glycaemic control. METHODS: In this 26‐week, double‐blind trial, patients wh...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Obes Metab
Glavni autori: Aroda, V. R., Bailey, T. S., Cariou, B., Kumar, S., Leiter, L. A., Raskin, P., Zacho, J., Andersen, T. H., Philis‐Tsimikas, A.
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2016
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5074260/
https://ncbi.nlm.nih.gov/pubmed/26990378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12661
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items